Aetna chief executive said Monday he was confident an antitrust review of the health insurer’s proposed purchase of smaller rival Humana would allow the deal to close in the second half of 2016, seeking to allay investor concerns.
Mark Bertolini said Aetna had already prepared for possible divestitures to address overlaps with Humana’s business in the largest-ever US health insurance deal. The two sides announced the $37 billion transaction on Friday.
“We took a conservative view of what we would need to divest,” Bertolini said during an investor conference call.
Aetna has not discussed the deal directly with the US Department of Justice, but has consulted with regulatory experts, Bertolini told cable channel CNBC.
“We believe that given the legal advice we have…that this is a very manageable transaction,” he said.
Full content: Fox Business
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Germany and France Advocate for Major EU Competition Reform
May 29, 2024 by
CPI
Equifax Accused of Monopolizing Employment Verification Market in New Suit
May 29, 2024 by
CPI
Car Battery Makers to Challenge EU Cartel Charges in Brussels
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI